financetom
Business
financetom
/
Business
/
Market Chatter: Parkland Turned Down Takeover Offer From Sunoco Last Year Amid Shareholder Dispute
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Parkland Turned Down Takeover Offer From Sunoco Last Year Amid Shareholder Dispute
Aug 9, 2024 8:36 AM

11:12 AM EDT, 08/09/2024 (MT Newswires) -- Calgary-based fuel retailer Parkland Corp. ( PKIUF ) rebuffed a takeover offer worth nearly $8-billion from Texas-based Sunoco LP ( SUN ) last year, The Globe and Mail has reported.

The proposal for a stock-based transaction was made in the summer of 2023 for $45 a share, according to a source familiar with the matter. That represented a roughly 28% premium to where Parkland shares were trading at the time and valued the Canadian company at about $7.9-billion. The Globe and Mail is not identifying the source because they were not authorized to discuss the bid publicly.

Parkland spokesperson Simon Scott said the company has a policy of not commenting on market speculation. The company disclosed this year that it received an offer in 2023, but provided no details on the bid's size or source, only that Parkland thought it undervalued the company.

(Market Chatter news is derived from conversations with market professionals globally, and/or from other media sources. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 36.05, Change: +0.71, Percent Change: +2.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Obesity drugmaker Novo Nordisk cuts 2025 outlook, posts Q1 profit above forecast
Obesity drugmaker Novo Nordisk cuts 2025 outlook, posts Q1 profit above forecast
May 26, 2025
COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk on Wednesday cut its full-year sales and profit outlook amid lacklustre U.S. prescription data and posted first-quarter operating profit above analyst forecasts. In the first quarter of 2025, we delivered 18% sales growth and continued to expand the reach of our innovative GLP-1 treatments, CEO Lars Fruergaard Jorgensen said in a statement. However, we...
Obesity drugmaker Novo Nordisk cuts 2025 outlook, posts Q1 profit above forecast
Obesity drugmaker Novo Nordisk cuts 2025 outlook, posts Q1 profit above forecast
May 26, 2025
COPENHAGEN, May 7 (Reuters) - Obesity drugmaker Novo Nordisk on Wednesday posted first-quarter operating profit above analyst forecasts and cut its operating profit and sales outlook for the year. ...
Sarepta Therapeutics Stock Plummets After Q1 Results: Here's Why
Sarepta Therapeutics Stock Plummets After Q1 Results: Here's Why
May 26, 2025
Sarepta Therapeutics, Inc. ( SRPT ) shares are sinking after the company released its first-quarter results after Tuesday's closing bell. Here's a look at the details from the report.  The Details: Sarepta Therapeutics ( SRPT ) reported quarterly losses of $3.42 per share, which missed the analyst consensus estimate of losses of 95 cents. Quarterly revenue came in at $744.86 million, which beat the...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved